Rawlings Datir

University of Cambridge — United Kingdom

Medicine · Health Sciences

18h-index5.7kcitations33works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(21), HIV Research and Treatment(8), HIV/AIDS drug development and treatment(8), SARS-CoV-2 detection and testing(8), COVID-19 Clinical Research Studies(6)

Publications33 total

SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity
Cell Reports·2022· 50 citedOpen Access
Author Correction: SARS-CoV-2 evolution during treatment of chronic infection
Nature·2022· 6 citedOpen Access
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature·2022· 3 citedOpen Access
SARS-CoV-2 Spike N-Terminal Domain modulates TMPRSS2-dependent viral entry and fusogenicity
2022· 6 citedOpen Access
Disengagement from HIV care and failure of second-line therapy in Nigeria: a retrospective cohort study, 2005-2017
UCL Discovery (University College London)·2022· 4 cited
Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria
Journal of Antimicrobial Chemotherapy·2021· 16 citedOpen Access
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Nature·2021· 1.4k citedOpen Access
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion
The Journal of Infectious Diseases·2021· 172 citedOpen Access
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Nature·2021· 789 citedOpen Access
SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthrough
2021· 94 citedOpen Access
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Cell Reports·2021· 446 citedOpen Access
SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies
Greater South Information System·2021· 47 citedOpen Access
Age-related heterogeneity in immune responses to SARS-CoV-2 following BNT162b2 vaccination
2021· 2 citedOpen Access
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature·2021· 712 citedOpen Access
SARS-CoV-2 evolution during treatment of chronic infection
Nature·2021· 1.1k citedOpen Access
Age-related heterogeneity in immune responses to SARS-CoV-2 vaccine BNT162b2
2021· 54 citedOpen Access
SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies
2021· 28 citedOpen Access
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
2021· 167 citedOpen Access
Age-Related Heterogeneity in Neutralising Antibody Responses to SARS-CoV-2 Following BNT162b2 Vaccination
SSRN Electronic Journal·2021· 13 citedOpen Access
Recurrent Emergence and Transmission of a SARS-CoV-2 Spike Deletion H69/V70
SSRN Electronic Journal·2021· 119 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Ravindra K. Gupta(19), Steven A. Kemp(17), Dami A. Collier(16), Isabella A.T.M. Ferreira(15), Bo Meng(11), Nathalie Kingston(10), Anne Elmer(10), Paul Lyons(9), Stuart Fawke(9), Patrick Dakum(9), James Thaventhiran(7), Kenneth G. C. Smith(7), John R. Bradley(7), Guido Papa(6), Adam Abdullahi(6), Daniela Caputo(6), Stephen Baker(6), Gordon Dougan(6), Christoph Hess(6), Paul J. Lehner(6)